ArticleCell reports. Medicine2025

Combined therapy with DR5-targeting antibody-drug conjugate and CDK inhibitors as a strategy for advanced colorectal cancer.

Dongdong Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.